ACRUX LIMITED - Announcements

11.1%

1.6¢

Market Cap $6.548M

Healthcare Drug Manufacturers - Specialty & Generic

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist, Dapsone Gel, 5% and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto (estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

ACR	Trading Halt	PRICE SENSITIVE	15/03/10	41.78KB	Share
ACR	Half Year Accounts and Appendix 4D	PRICE SENSITIVE	24/02/10	281.88KB	Share
ACR	Appendix 4C - Quarterly Cash Flow	PRICE SENSITIVE	29/01/10	89.3KB	Share
ACR	Acrux Submits New Drug Application for AXIRON to FDA	PRICE SENSITIVE	27/01/10	768.01KB	Share
ACR	Appendix 4C - Quarterly Cash Flow	PRICE SENSITIVE	30/10/09	89.25KB	Share
ACR	Acrux Announces Successful AXIRON Phase 3 Trial Results	PRICE SENSITIVE	29/09/09	86.73KB	Share
ACR	Acrux Signs Ellavie Distribution Agreement for Key European	PRICE SENSITIVE	24/09/09	89.94KB	Share
ACR	Acrux to proceed with AXIRON NDA following meeting with FDA	PRICE SENSITIVE	03/09/09	93.14KB	Share
ACR	Appendix 4E and 30 June 2009 Financial Report	PRICE SENSITIVE	27/08/09	3.6MB	Share
ACR	Appendix 4C - Quarterly Cash Flow	PRICE SENSITIVE	30/07/09	89.37KB	Share
ACR	Acrux signs Ellavie distribution agreement for South Korea	PRICE SENSITIVE	10/07/09	84.32KB	Share
ACR	Acrux signs Ellavie distribution agreement for Switzerland	PRICE SENSITIVE	19/06/09	27.04KB	Share
ACR	Arbitration Panel Rules in Favour of Acrux	PRICE SENSITIVE	19/06/09	43.39KB	Share
ACR	Acrux signs Ellavie Distribution Agreement for South Africa	PRICE SENSITIVE	04/06/09	82.61KB	Share
ACR	Response to an ASX Price Query	PRICE SENSITIVE	02/06/09	128.9KB	Share
ACR	Response to an ASX Price Query	PRICE SENSITIVE	12/05/09	128.91KB	Share
ACR	Appendix 4C - Quarterly Cash Flow	PRICE SENSITIVE	23/04/09	89.34KB	Share
ACR	Acrux receives interim arbitration ruling	PRICE SENSITIVE	14/04/09	26.27KB	Share
ACR	Acrux completes enrolment in Phase 3 trial of AXIRON	PRICE SENSITIVE	09/03/09	371.2KB	Share
ACR	Update on Evamist and KV Pharmaceutical	PRICE SENSITIVE	03/03/09	30.33KB	Share
ACR	Half Year Accounts and Appendix 4D	PRICE SENSITIVE	25/02/09	178.26KB	Share
ACR	Positive clinical trial results for contraceptive spray	PRICE SENSITIVE	20/02/09	51.33KB	Share
ACR	Appendix 4C quarterly cash flow report	PRICE SENSITIVE	30/01/09	32.63KB	Share
ACR	Acrux ceases investment in Fentanyl MDTS	PRICE SENSITIVE	30/01/09	19.59KB	Share
ACR	Response to an ASX Price Query	PRICE SENSITIVE	12/01/09	107.75KB	Share
ACR	SUBMISSION TO FDA OF FIRST ANIMAL HEALTH PRODUCT	PRICE SENSITIVE	15/12/08	20.81KB	Share
ACR	Enrolment 50% completed in testosterone lotion Phase 3 trial	PRICE SENSITIVE	20/11/08	39.23KB	Share

ACR Trading Halt
15/03/10	PRICE SENSITIVE	41.78KB	Share
ACR Half Year Accounts and Appendix 4D
24/02/10	PRICE SENSITIVE	281.88KB	Share
ACR Appendix 4C - Quarterly Cash Flow
29/01/10	PRICE SENSITIVE	89.3KB	Share
ACR Acrux Submits New Drug Application for AXIRON to FDA
27/01/10	PRICE SENSITIVE	768.01KB	Share
ACR Appendix 4C - Quarterly Cash Flow
30/10/09	PRICE SENSITIVE	89.25KB	Share
ACR Acrux Announces Successful AXIRON Phase 3 Trial Results
29/09/09	PRICE SENSITIVE	86.73KB	Share
ACR Acrux Signs Ellavie Distribution Agreement for Key European
24/09/09	PRICE SENSITIVE	89.94KB	Share
ACR Acrux to proceed with AXIRON NDA following meeting with FDA
03/09/09	PRICE SENSITIVE	93.14KB	Share
ACR Appendix 4E and 30 June 2009 Financial Report
27/08/09	PRICE SENSITIVE	3.6MB	Share
ACR Appendix 4C - Quarterly Cash Flow
30/07/09	PRICE SENSITIVE	89.37KB	Share
ACR Acrux signs Ellavie distribution agreement for South Korea
10/07/09	PRICE SENSITIVE	84.32KB	Share
ACR Acrux signs Ellavie distribution agreement for Switzerland
19/06/09	PRICE SENSITIVE	27.04KB	Share
ACR Arbitration Panel Rules in Favour of Acrux
19/06/09	PRICE SENSITIVE	43.39KB	Share
ACR Acrux signs Ellavie Distribution Agreement for South Africa
04/06/09	PRICE SENSITIVE	82.61KB	Share
ACR Response to an ASX Price Query
02/06/09	PRICE SENSITIVE	128.9KB	Share
ACR Response to an ASX Price Query
12/05/09	PRICE SENSITIVE	128.91KB	Share
ACR Appendix 4C - Quarterly Cash Flow
23/04/09	PRICE SENSITIVE	89.34KB	Share
ACR Acrux receives interim arbitration ruling
14/04/09	PRICE SENSITIVE	26.27KB	Share
ACR Acrux completes enrolment in Phase 3 trial of AXIRON
09/03/09	PRICE SENSITIVE	371.2KB	Share
ACR Update on Evamist and KV Pharmaceutical
03/03/09	PRICE SENSITIVE	30.33KB	Share
ACR Half Year Accounts and Appendix 4D
25/02/09	PRICE SENSITIVE	178.26KB	Share
ACR Positive clinical trial results for contraceptive spray
20/02/09	PRICE SENSITIVE	51.33KB	Share
ACR Appendix 4C quarterly cash flow report
30/01/09	PRICE SENSITIVE	32.63KB	Share
ACR Acrux ceases investment in Fentanyl MDTS
30/01/09	PRICE SENSITIVE	19.59KB	Share
ACR Response to an ASX Price Query
12/01/09	PRICE SENSITIVE	107.75KB	Share
ACR SUBMISSION TO FDA OF FIRST ANIMAL HEALTH PRODUCT
15/12/08	PRICE SENSITIVE	20.81KB	Share
ACR Enrolment 50% completed in testosterone lotion Phase 3 trial
20/11/08	PRICE SENSITIVE	39.23KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.6¢		Change -0.002(11.1%)		Mkt cap ! $6.548M

Open	High	Low	Value	Volume
2.0¢	2.0¢	1.6¢	$39.34K	2.216M

Buyers (Bids)

No.	Vol.	Price($)
8	971151	1.6¢

Sellers (Offers)

Price($)	Vol.	No.
1.7¢	565000	1

View Market Depth

No.	Vol.	Price($)
8	971151	0.016
4	1111882	0.015
2	140000	0.014
3	486850	0.013
1	80000	0.012

Price($)	Vol.	No.
0.017	565000	1
0.018	435000	1
0.019	315901	1
0.020	56616	4
0.021	111922	1

Last trade - 16.10pm 31/07/2025 (20 minute delay)


Last 1.7¢		Change -0.002 ( 5.56 %)
Open	High	Low	Volume
1.9¢	1.9¢	1.7¢	519248
Last updated 14.23pm 31/07/2025 ?

ACR (ASX) Chart

ACRUX LIMITED - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

A new NASDAQ listing for a key player in the global critical minerals space

Top Stories

ACRUX LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

A new NASDAQ listing for a key player in the global critical minerals space

Top Stories

Corporate Spotlight
Not Yet Available